April 11, 2018
Melbourne, Australia-based Global Kinetics Corporation, maker of a wearable Parkinson’s disease monitor, has received a $7.75 million investment from the Australian Federal Government’s Biomedical Translation Fund, according to news from the Australian Financial Review that was confirmed by MobiHealthNews.
The investment came from Brandon Capital, which manages nearly half of the government fund...
April 11, 2018
Engineering students at Rice University have created a new iPhone app they say could help patients with Parkinson's manage a symptom of the disease called "freezing," a temporary and involuntary inability to move when the legs are unable to follow the brain's command.
Visual, audio or vibratory cues can help overcome that, research has shown, and the Rice developers say their new app offers a...
April 9, 2018
Capturing a patient’s experience outside the doctor’s office has been an ongoing struggle when it comes to treating Parkinson’s disease. But now a new smartphone app can now detect the severity of symptoms in patients with Parkinson’s disease remotely, according to a recent study published by JAMA.
Researchers at Johns Hopkins University, the University of Rochester Medical Center and Aston...
January 19, 2017
People with Parkinson’s disease who used an app to track and manage symptom improved their medication adherence and had better conversations with clinicians about their condition, according to the results of a recent National Health Services study published in the journal Nature Parkinson’s.
Representing the largest randomized controlled trial of a digital technology for Parkinson’s Disease,...
January 5, 2017
Cambridge-based MC10, which makes paper-thin adhesive health sensors, and Belgium-based pharma company UCB have completed the Parkinson's study they began in 2014 and are aiming to publish the results later this year, the two companies announced.
The study used MC10's adhesive sensors to collect movement data on Parkinson's patients, combined with patient-reported outcomes and neurological...
November 28, 2016
Since its well-publicized meeting with the FDA in 2013, Apple has continued to meet with the agency regularly as well as to correspond by phone and email, according to emails obtained by MobiHealthNews via a Freedom of Information Act request to the FDA.
These emails show that Apple and the FDA have discussed the App Store review process, the 510(k) process, ResearchKit apps, diagnostic apps,...
November 28, 2016
Apple is working closely with the FDA to develop an FDA-regulated app for diagnosing Parkinson’s disease, MobiHealthNews has learned. The insight comes from a batch of emails MobiHealthNews obtained from a Freedom of Information Act request to the FDA.
The tech giant held a meeting about Parkinson's at its headquarters in Cupertino in September 2015 attended by a number of neurologists and...
March 21, 2016
At an event in Cupertino today, Apple announced that it would take its ResearchKit framework and spin off a new, similar offering called CareKit, an open source toolkit for hospitals and health systems. CareKit will launch with two applications: one for home monitoring of Parkinson's and one for post-surgical discharge.
"When we introduced ResearchKit, our goal was to improve medical research and...
August 13, 2015
Roche Pharma Research and Early Development, a division of Roche Pharmaceuticals, has developed a new mobile app to measure Parkinson's disease symptoms. The app was developed in partnership with Max Little, a British mathametician at the head of the Parkinson's Voice Initiative, and it will actually be used in a drug development trial with Prothena Biosciences.
“The app is being used in a Phase...
March 17, 2015
Great Lakes NeuroTechnologies, which makes mobile software and wearable devices for monitoring symptoms of Parkinson's disease, has released a new clinical version of its technology that supports continuous monitoring. Kinesia 360 is still a clinician-facing tool; it doesn't appear to be the direct-to-consumer offering the company promised last April when it received a $1.5 million NIH grant.